I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Massó-Vallés, D.
52
results:
Search for persons
X
Format
Online (52)
Mediatypes
Articles (Online) (19)
OpenAccess-fulltext (33)
Languages
english (46)
spanish (2)
Sorted by: Relevance
Sorted by: Year
?
1
Omomyc as a novel therapeutic strategy against metastatic t..:
Giuntini, F.
;
Massó-Vallés, D.
;
González-Larreategui, Í.
...
European Journal of Cancer. 174 (2022) - p. S53-S54 , 2022
Link:
https://doi.org/10.1016/..
?
2
MYC inhibition by Omomyc unveils a prognostic gene signatur..:
Zacarias-Fluck, M.
;
Massó-Vallés, D.
;
Kaur, J.
...
European Journal of Cancer. 174 (2022) - p. S38-S39 , 2022
Link:
https://doi.org/10.1016/..
?
3
MYC inhibition by OMO-103 induces immune cell recruitment i..:
Casacuberta Serra, S.
;
Martínez-Martín, S.
;
González-Larreategui, Í.
...
European Journal of Cancer. 174 (2022) - p. S46-S47 , 2022
Link:
https://doi.org/10.1016/..
?
4
Pancreatic cancer heterogeneity and response to Mek inhibit..:
Pedersen, K
;
Bilal, F
;
Bernadó Morales, C
...
Oncogene. 36 (2017) 40 - p. 5639-5647 , 2017
Link:
https://doi.org/10.1038/..
?
5
773: A novel pharmacological approach to inhibit Myc in can..:
Beaulieu, M.E.
;
Whitfield, J.R.
;
Jauset, T.
...
European Journal of Cancer. 50 (2014) - p. S186 , 2014
Link:
https://doi.org/10.1016/..
?
6
749 Myc – a Non Redundant Function in Cancer:
Soucek, L.
;
Whitfield, J.R.
;
Sodir, N.M.
...
European Journal of Cancer. 48 (2012) - p. S177 , 2012
Link:
https://doi.org/10.1016/..
?
7
916 Modeling Pharmacological Inhibition of Bruton's Tyrosin..:
Soucek, L.
;
Masso-Valles, D.
;
Jauset, T.
...
European Journal of Cancer. 48 (2012) - p. S222 , 2012
Link:
https://doi.org/10.1016/..
?
8
MYC targeting by OMO-103 in solid tumors: a phase 1 trial:
Garralda, Elena
;
Beaulieu, Marie-Eve
;
Moreno, Víctor
...
Nature Medicine. 30 (2024) 3 - p. 762-771 , 2024
Link:
https://doi.org/10.1038/..
?
9
Reducing MYC's transcriptional footprint unveils a good pro..:
Zacarías-Fluck, Mariano F.
;
Massó-Vallés, Daniel
;
Giuntini, Fabio
...
Genes & Development. 37 (2023) 7-8 - p. 303-320 , 2023
Link:
https://doi.org/10.1101/..
?
10
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural..:
Beaulieu, Marie-Eve
;
Martínez-Martín, Sandra
;
Kaur, Jastrinjan
...
Cancers. 15 (2023) 3 - p. 826 , 2023
Link:
https://doi.org/10.3390/..
?
11
MYC Inhibition Halts Metastatic Breast Cancer Progression b..:
Massó-Vallés, Daniel
;
Beaulieu, Marie-Eve
;
Jauset, Toni
...
Cancer Research Communications. 2 (2022) 2 - p. 110-130 , 2022
Link:
https://doi.org/10.1158/..
?
12
The Wnt signaling receptor Fzd9 is essential for Myc-driven..:
Zacarías-Fluck, Mariano F
;
Jauset, Toni
;
Martínez-Martín, Sandra
...
Life Science Alliance. 4 (2021) 5 - p. e201900490 , 2021
Link:
https://doi.org/10.26508..
?
13
Blocking Myc to Treat Cancer: Reflecting on Two Decades of ..:
Massó-Vallés, Daniel
;
Soucek, Laura
Cells. 9 (2020) 4 - p. 883 , 2020
Link:
https://doi.org/10.3390/..
?
14
BET inhibition is an effective approach against KRAS-driven..:
Jauset, Toni
;
Massó-Vallés, Daniel
;
Martínez-Martín, Sandra
...
Oncotarget. 9 (2018) 27 - p. 18734-18746 , 2018
Link:
https://doi.org/10.18632..
?
15
Ibrutinib repurposing: from B-cell malignancies to solid tu..:
Massó-Vallés, Daniel
;
Jauset, Toni
;
Soucek, Laura
Oncoscience. 3 (2016) 5-6 - p. 147-148 , 2016
Link:
https://doi.org/10.18632..
1-15